LIGABUE, Giulia
 Distribuzione geografica
Continente #
EU - Europa 7.998
NA - Nord America 7.957
AS - Asia 4.440
SA - Sud America 565
AF - Africa 121
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.099
Nazione #
US - Stati Uniti d'America 7.762
IT - Italia 4.758
SG - Singapore 1.324
CN - Cina 1.226
DE - Germania 809
GB - Regno Unito 765
VN - Vietnam 506
HK - Hong Kong 475
BR - Brasile 414
SE - Svezia 373
RU - Federazione Russa 280
NL - Olanda 206
FR - Francia 198
BD - Bangladesh 196
FI - Finlandia 172
KR - Corea 149
IN - India 113
CA - Canada 108
TR - Turchia 92
UA - Ucraina 84
ID - Indonesia 83
AR - Argentina 57
BG - Bulgaria 53
MX - Messico 53
JP - Giappone 48
ES - Italia 44
IQ - Iraq 36
ZA - Sudafrica 32
PL - Polonia 31
CH - Svizzera 29
PK - Pakistan 27
MA - Marocco 26
BE - Belgio 23
CZ - Repubblica Ceca 22
AT - Austria 19
IE - Irlanda 19
IR - Iran 19
MY - Malesia 19
EC - Ecuador 18
VE - Venezuela 18
LT - Lituania 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
CO - Colombia 15
PT - Portogallo 13
UZ - Uzbekistan 13
AU - Australia 12
PE - Perù 12
RO - Romania 12
AZ - Azerbaigian 11
DZ - Algeria 11
EG - Egitto 11
IL - Israele 11
KE - Kenya 10
TW - Taiwan 10
AL - Albania 9
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
CR - Costa Rica 8
DK - Danimarca 8
JO - Giordania 8
MT - Malta 8
SI - Slovenia 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NO - Norvegia 6
NP - Nepal 6
PA - Panama 6
NG - Nigeria 5
RS - Serbia 5
GR - Grecia 4
HR - Croazia 4
JM - Giamaica 4
MD - Moldavia 4
OM - Oman 4
BO - Bolivia 3
GE - Georgia 3
KH - Cambogia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BH - Bahrain 2
EU - Europa 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 21.073
Città #
Singapore 857
Ashburn 831
Santa Clara 743
Fairfield 548
Hong Kong 459
Southend 459
San Jose 454
Milan 431
Hefei 428
Chandler 392
Rome 324
Woodbridge 291
Houston 260
Seattle 213
Cambridge 205
Wilmington 204
Council Bluffs 200
Beijing 197
Nyköping 187
Ann Arbor 168
London 166
Ho Chi Minh City 159
Naples 143
Jacksonville 141
Seoul 139
Dearborn 133
New York 129
Los Angeles 125
Hanoi 124
Modena 119
Helsinki 116
Bologna 89
The Dalles 89
Dallas 82
Bari 73
Munich 73
Turin 70
Florence 66
Frankfurt am Main 62
Lauterbourg 62
Chicago 57
Moscow 53
Buffalo 52
Jakarta 52
San Diego 50
Parma 49
São Paulo 48
Princeton 47
Sofia 47
Catania 45
Orem 43
Shanghai 42
Izmir 39
Palermo 38
Tokyo 36
Genoa 33
Eugene 32
Fremont 32
Verona 32
Brescia 30
Nuremberg 30
Des Moines 29
Redwood City 29
Reggio Emilia 29
Phoenix 28
Toronto 28
Montreal 26
Atlanta 25
Padova 25
Falls Church 24
Guangzhou 24
Warsaw 24
Boardman 23
Cagliari 23
Denver 23
Kent 22
Da Nang 21
Lucca 21
Salerno 21
Columbus 20
Livorno 20
Turku 20
Monza 19
Salt Lake City 19
Durham 18
Venice 18
Amsterdam 17
Bremen 17
Brooklyn 17
Baghdad 16
Brussels 16
Haiphong 16
Mexico City 16
Perugia 16
Poplar 16
Chennai 15
Norwalk 15
Tampa 15
Wuhan 15
Dublin 14
Totale 11.698
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.282
The Role of PEC Progenitors in ADPKD Progression 1.106
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 427
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 412
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 405
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 393
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 373
Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model 371
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 366
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 359
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 351
P-Cresol and Cardiovascular Risk in Kidney Transplant Recipients 346
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 340
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 340
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 333
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 326
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 324
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 324
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 316
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 293
[Dyslipidemia and the risk of kidney disease]. 286
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 286
Water treatment and monitor disinfection 279
Relapse of atypical hemolytic uremic syndrome during pregnancy in a patient on eculizumab maintenance treatment: A case report 275
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 274
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 269
Acid base disorders in patients with COVID-19 263
A validated model of disease progression in IgA nephropathy 260
In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis 253
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 252
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 249
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 246
Post-transplant recurrence of glomerulonephritis: a complex clinical case. 240
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 240
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 238
Interstitiome: a novel proteomic discipline applied to renal biopsy 236
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 233
FP808EARLY IDENTIFICATION OF SICKLE CELL NEPHROPATHY IN A COHORT OF CHILDREN WITH SICKLE CELL DISEASE 233
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 232
P-cresolo solfato e rischio cardiovascolare nel paziente trapiantato 226
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 225
Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial 222
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 214
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 212
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 199
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 195
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 188
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 185
AKI in hospitalized patients with COVID-19: a single-center experience 183
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 175
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 174
Rethinking Chronic Kidney Disease in the Aging Population 168
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 153
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 146
Il centro dialisi ecosostenibile 140
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 135
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 130
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 127
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 127
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 118
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 117
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 115
Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center 105
Formative usability test of a novel device for peritoneal dialysis (WEAKID) 102
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 94
Validation of Hemoglobin and Hematocrit Measurements from a Dialysis Machine Sensor Compared to Laboratory Analysis: A Cross-Sectional Study 83
A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement 68
Sustainable kidney care: A life cycle assessment of the peritoneal dialysis pathways 48
Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up 37
Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis 36
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach 30
#2314 Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital 28
Assessing middle-molecular and protein-bound uremic toxins: a six month study of ATA vs PS membranes in hemodiafiltration 27
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy 26
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy 25
Twelve-Month Evaluation of Middle Molecule (MMUT) and Protein-Bound Uremic Toxin (PBUT) Removal with Two Different Hemodiafiltration Filters 21
Genomic Approaches for Monogenic Kidney Diseases: A Comparative Review of Diagnostic Methods and Precision Medicine Implications 6
Totale 21.241
Categoria #
all - tutte 65.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 0 58
2021/20221.117 71 93 65 110 50 98 53 54 107 77 213 126
2022/20231.981 126 173 94 171 168 274 136 216 189 113 179 142
2023/20242.501 111 118 200 244 291 246 302 255 119 181 201 233
2024/20254.429 245 232 230 345 624 605 401 281 435 202 375 454
2025/20267.304 454 295 498 694 828 383 864 334 680 699 1.422 153
Totale 21.241